Blogs November 27, 2023From Transparency to Gold Carding, 5 PBM State Regulation Trends from ’23Read Now
Blogs November 16, 2023Newly Broadened 340B Patient Definition: How the Latest Genesis Court Decision Could Impact The Entire IndustryWatch Now
Blogs October 4, 2023Shark vs. Pharma: Can Cuban’s Cost Plus Drugs Make a Real Impact on Medication Prices?Read Now
Blogs September 25, 2023Appeals Court Decision Favoring PCMA Leaves Questions for ERISA PlansRead Now
Blogs June 28, 2023Biosimilars, GLP-1s, and Stop-loss: Topics Benefit Advisors Need to Consider in Q3 2023Read Now
Blogs June 14, 2023After 20 Years of Humira Prescriptions, Therapeutic Interchange Programs Give Employers Much-Needed OptionsRead Now
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.